Ireland - English - HPRA (Health Products Regulatory Authority)

forte healthcare ltd - enrofloxacin - solution for injection - 50 milligram(s)/millilitre - enrofloxacin - cats, cattle, dogs, pigs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - enrofloxacin - tablet - 150 milligram(s) - enrofloxacin - dogs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - enrofloxacin - tablet - 50 mg/tablet - enrofloxacin - dogs - antibacterial

United States - English - NLM (National Library of Medicine)

bayer healthcare llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn), butyl alcohol (unii: 8pj61p6ts3) (butyl alcohol - unii:8pj61p6ts3) - enrofloxacin 22.7 mg in 1 ml - baytril® (brand of enrofloxacin) injectable solution is indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin. efficacy confirmation: clinical efficacy was established in dermal infections (wounds and abscesses) associated with susceptible strains of escherichia coli , klebsiella pneumoniae , proteus mirabilis , and staphylococcus intermedius ; respiratory infections (pneumonia, tonsillitis, rhinitis) associated with susceptible strains of escherichia coli and staphylococcus aureus ; and urinary cystitis associated with susceptible strains of escherichia coli , proteus mirabilis , and staphylococcus aureus . enrofloxacin is contraindicated in dogs known to be hypersensitive to quinolones. based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in lar

United States - English - NLM (National Library of Medicine)

bayer healthcare llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn), silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - enrofloxacin 5 mg in 1 ml - baytril® otic is indicated as a treatment for canine otitis externa complicated by bacterial and fungal organisms susceptible to enrofloxacin and/or silver sulfadiazine (see microbiology section). baytril® otic is contraindicated in dogs with suspected or known hypersensitivity to quinolones and/or sulfonamides.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

aether centre (beijing) biology co., limited, china - enrofloxacin - injection - 100 mg/ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - enrofloxacin - unknown - enrofloxacin antibiotic active 0.0 - active constituent

New Zealand - English - Ministry for Primary Industries

randlab australia pty ltd - enrofloxacin - enrofloxacin 100 g/litre - antibiotic

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

my vet care sdn bhd - enrofloxacin -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

headway investments pty ltd - enrofloxacin - parenteral liquid/solution/suspension - enrofloxacin antibiotic active 50.0 mg/ml - antibiotic & related